HK Stock MarketDetailed Quotes
02162 KEYMED BIO-B
- 39.350
- -1.050-2.60%
Market Closed Nov 15 16:08 CST
11.01BMarket Cap-13522P/E (TTM)
41.600High38.300Low961.50KVolume41.550Open40.400Pre Close38.05MTurnover0.34%Turnover RatioLossP/E (Static)279.74MShares57.30052wk High3.81P/B11.01BFloat Cap26.60052wk Low--Dividend TTM279.74MShs Float82.850Historical High--Dividend LFY8.17%Amplitude16.900Historical Low39.573Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
KEYMED BIO-B Key Stats
EPS
According to the latest financial report of KEYMED BIO-B, the latest earnings per share (TTM) for the company is -1.41. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out KEYMED BIO-B's latest financial report to see how much their book value per share (BVPS) is currently at 10.33.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of KEYMED BIO-B shows that the company's current ratio is 4.98, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of KEYMED BIO-B, the quick ratio is 4.83, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of KEYMED BIO-B? The latest ROE figure is -11.93%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of KEYMED BIO-B, the total asset return on investment (ROA) is -8.73%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check KEYMED BIO-B's latest financial report to see how their gross margin is doing - currently at 93.17%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of KEYMED BIO-B, the net profit margin is -615.56%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data